申请人:Eli Lilly and Company
公开号:US08106077B2
公开(公告)日:2012-01-31
Compounds of formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
公式(I)的化合物被披露为治疗血脂异常和相关疾病的有用药物组合物,并且其变量定义如本文所述。